Cairo (EG), Muenster (DE), 11 October, 2012. At a 3-day workshop in Cairo, pharmaceutical service provider Diapharm (www.diapharm.com) presented the European regulations on medication demarcation areas to representatives of the Egyptian Ministry of Health. Currently, Egypt is revising its legislation regarding medical products, nutritional supplements and self-medication products and is considering, at least partially, taking into account EU legislation. The objective is to improve the availability of safer products.

“Diapharm provided us with insights into EU regulatory practice and to some extent, different national implementations.” summarised Safa Ibrahim, responsible for implementing the medical devices regulation at the Egyptian Ministry of Health. GlaxoSmithKline Middle East had facilitated the contact. Dr. Guido Middeler and Dorothee Klöpf from Diapharm were invited to present to approximately 40 participants from various departments of the Ministry, the EU regulations on medical products and their demarcation from herbal medicinal products and nutritional supplements.

To some extent the experts also made a case for approaches that go beyond those of the European Union. “An orientation to the regulatory model of the Global Harmonization Task Force for medical products is to be recommended, on which, the EU, the USA, Canada, Australia and Japan are working” emphasized Dr. Guido Middeler: “In this way, Egypt would directly achieve maximum international harmonization and safer products would be more speedily available.” Among other topics discussed in the Cairo workshop was whether joint solutions that went beyond national borders might be meaningful.

(ca. 1,680 characters)

Diapharm is an international full-service provider to the healthcare industry. Founded in 1988, Diapharm supports pharmaceutical companies in all questions concerning regulatory affairs, medical & clinical development, quality management and business development. Its activities focus on the sectors of medicinal products, food supplements and dietetic food, medical devices and cosmetics. With about 100 employees in Germany, Austria and the United Kingdom, Diapharm is at the service of multinational companies as well as of recent start-ups and small to mid-sized businesses.

Contact:
Diapharm
Press Office
Hafenweg 18-20
D-48155 Münster

Contact person:
Nicole Sibbing

Tel.: +49 (0)251 - 60935-517
nicole.sibbing@diapharm.de
www.diapharm.de

Agency contact:
co-operate Wegener & Rieke GmbH
Zumsandestraße 32
D-48145 Münster

Contact person:
Christian Rieke

Tel.: +49 (0)251 - 3222611
wort@co-operate.net
www.co-operate.net

This release was published on openPR.